期刊文献+

硝唑沙奈肠溶缓释颗粒体外释放度的测定

Determination of the in vitro release rate of nitazoxanide enteric sustained-release particle
下载PDF
导出
摘要 【目的】建立硝唑沙奈肠溶缓释颗粒体外释放度的测定方法,为控制肠溶缓释颗粒剂的质量及提高硝唑沙奈(NTZ)治疗畜禽肠道疾病的效果提供参考依据。【方法】采用转篮法[转速75r/min,温度(37.0±0.5)℃,释放介质前2h为750mL2%十六烷基三甲基溴化铵(CTAB)0.1mol/mLHCl溶液,后加入250mL2%CTAB0.2mol/mL磷酸盐缓冲溶液,pH6.8,总体积1000mL]进行硝唑沙奈肠溶缓释颗粒的溶出试验,分别在不同时间点取样,以高效液相色谱—紫外检测(HPLC-UV)法测定峰面积,计算硝唑沙奈的体外累积释放度,并对释药模型进行拟合。【结果】硝唑沙奈及替唑尼特在2%CTAB0.1mol/mLHCl和2%CTAB磷酸盐缓冲液(pH6.8)两种介质中的理论塔板数均大于3000,分离度均大于2.0。精密度试验、重复性试验、稳定性试验、回收率试验、释放度均一性试验等均表明,HPLC-UV法适用于硝唑沙奈肠溶缓释颗粒体外释放度的测定。硝唑沙奈肠溶缓释颗粒在前2h内的累积释放量<10.0%,至24h时释放度大于90.0%,符合药品释放度检测要求。硝唑沙奈肠溶缓释颗粒体外释放的最佳拟合模型为Higuchi模型。【结论】HPLC-UV法是测定硝唑沙奈肠溶缓释颗粒体外释放度的有效方法,具有准确可靠、重复性良好、回收率高的特点。 [Objective]The dissolution of nitazoxanide enteric sustained-release particle was determined to provide references for its quality control and treatment improvement. [Method]Release tests were carried out using rotating basket method [rotating speed :75 r/min, temperature (37±0.5)℃ ,750 mL 0.1 mol/mL hydrochloric acid solution (containing 2% eetyl trimethyl ammonium bromide) for the initial 2 h, 250 mL 0.2 mol/mL sodium phosphate solution (containing 2% CTAB), pH 6.8, total volume 1000 mL] Peak area of the samples collected at differenl time was measured using HPLC- UV, and then the external accunmlative release rate of nitazoxanide was calculated, finally the drug release model was fit- ted. [Result ]Number of theoretical plates of nitazoxanide and tizoxanide was over 3000 in 2% CTAB 0.1 mol/mL HC1 and 2% CTAB phosphate buffer (pH 6.8), and their resolution was more than 2.0. The experiments of precision, repetition, stability, recovery and release proved that HPLC-UV was suitable for the detection of nitazoxauide enteric sustained-re- lease particle. The accumulated resolution of nitazoxanide enteric sustained-release particle in 2 h was less than 10.0%, and in 2-22 h, more than 90.0%, which accorded with the requirements of dl^ag release rate. Higuchi model was found to be the best fitting model. [Conclusion]Due to its accuracy, repeatability and high recovery, HPLC-UV was the effective method for determining the release rate of nitazoxanide enteric sustained-release particle.
出处 《南方农业学报》 CAS CSCD 北大核心 2013年第2期312-317,共6页 Journal of Southern Agriculture
基金 上海市科委成果转化项目(9083919N1100)
关键词 硝唑沙奈 肠溶缓释颗粒 释放度 高效液相色谱-紫外检测法 Higuchi模型 nitazoxanide enteric sustained-release particle release rate high performance liquid chromatography( HPLC )-UV assay Higuchi model
  • 相关文献

参考文献8

二级参考文献39

  • 1吴琼珠,戴永健,刘卫卫,吴立云.HPLC测定甲钴胺的有关物质[J].南京军医学院学报,2003,25(4):221-222. 被引量:3
  • 2彭德旺,黄秀萍.犬的绦虫种类及绦虫病防治[J].养犬,1993,4(2):3-9. 被引量:1
  • 3陈乔.高效液相色谱法测定原料药甲钴胺的含量[J].河北化工,2006,29(2):54-54. 被引量:3
  • 4The National Pharmacopoeia Commission of P R China(中华人民共和国国家药典委员会).General Name of Drugs of China(中国药品通用名称).Beijing(北京):Chemical Industry Press(化学工业出版社),1997.155.
  • 5Cynthia Theodos. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models antimicbial. Agents Chemotherapy, 1998,42 ( 8 ) : 1959.
  • 6Rossignol J F, Hidalgo H,Feregrino M,et al. A double- ' blind' placebo - controlled study of nitazoxamide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg ,1998 ,92 ( 6 ) :663.
  • 7Broekhugzen J, Stockis A, Lins R L, et al. Nitazoxanide : pharmacoki-netics and metabolism in man. Int J Clin Pharmacol Ther,2000,38(8) :387.
  • 8MAKHJIA S N, VAVIA P R. Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations[ J]. Pharm Biomed Anal, 2002,28 ( 6 ) : 1055-1059.
  • 9Murphy JR, Friedmann JC. Pre-clinical Toxicology of Nitazoxanide-A New Antiparasitic Compound[J]. J Appl Toxicol,1985,5(2) :49-52.
  • 10Rossognol JF, Maisonneuve H. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana[J]. Am J Trop Med Hyg,1984,33:511-512.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部